tiprankstipranks
Trending News
More News >

PolyNovo Releases May 2025 Investor Update Webcast Recording

Story Highlights
PolyNovo Releases May 2025 Investor Update Webcast Recording

Confident Investing Starts Here:

Polynovo ( (AU:PNV) ) has provided an update.

PolyNovo has released a recording of its May 2025 Investor Update Webcast for shareholders and interested parties who missed the live event. This announcement underscores PolyNovo’s commitment to transparency and stakeholder engagement, potentially strengthening its market position and investor relations.

The most recent analyst rating on (AU:PNV) stock is a Buy with a A$2.50 price target. To see the full list of analyst forecasts on Polynovo stock, see the AU:PNV Stock Forecast page.

More about Polynovo

PolyNovo is a disruptive medical technology company based in Melbourne, Australia, specializing in products that simplify the management of acute complex wounds. The company has treated over 70,000 patients across 46 countries and is focused on growth through new products, indications, and market expansion. Its flagship product, NovoSorb BTM, is a dermal scaffold used for dermis regeneration after surgery, trauma, or burns, known for its biocompatibility and customizable bio-resorption properties.

Average Trading Volume: 3,155,378

Technical Sentiment Signal: Sell

Current Market Cap: A$1.15B

For a thorough assessment of PNV stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App